Skip to main content
Caplight Logo









Aummune

Aummune

Private
Tel AvivHealthcare & Life Scienceshttps://aummune.com/

Company Overview

Aummune is a biotechnology company that develops individualized oligonucleotide-based immunotherapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

immunotherapyprecision medicineoligonucleotide therapycancer immunotherapypersonalized medicineoncologybiopharmaceuticaldrug discoverysolid tumor treatmentclinical trialsbiotechdrug customizationcomputational biologyai drug discoveryin silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aummune Comparables

Compare Aummune with similar companies based on industry and business-model similarity.

Aummune comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Imvax
83%
Aptabridge Therapeutics
79%
Scopus BioPharma Inc.
76%

Aummune Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Aummune Filings

Explore SEC and related filing metadata, where available.

Aummune filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aummune's valuation, stock price, and market status.

Is Aummune a public or private company?

Aummune is a private company.

What is the current stock price of Aummune?

Aummune is a private company with no public stock price. Caplight tracks Aummune's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Aummune worth (valuation)?

Valuation information for Aummune is not publicly available.

Can I buy Aummune stock?

Aummune shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aummune's last funding round?

Funding round information for Aummune is not publicly available.

Who are the main investors in Aummune?

Investor information for Aummune is not publicly disclosed.

Will Aummune IPO soon?

No public IPO plans have been announced for Aummune.

How can I track Aummune secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aummune's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range5
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?